Abeona Therapeutics Inc. (LON:0H7R)
5.34
-0.13 (-2.34%)
At close: May 9, 2025
Abeona Therapeutics Employees
Abeona Therapeutics had 136 employees as of December 31, 2024. The number of employees increased by 52 or 61.90% compared to the previous year.
Employees
136
Change (1Y)
52
Growth (1Y)
61.90%
Revenue / Employee
n/a
Profits / Employee
-374.33K GBP
Market Cap
192.35M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Genus | 3,500 |
Abeona Therapeutics News
- 9 days ago - Abeona Surges After FDA Clears First Gene Therapy For Severe Genetic Skin Disease - Benzinga
- 9 days ago - Abeona Surges After FDA Clears First Gene Therapy For Severe Genetic Skin Disease - Benzinga
- 9 days ago - Abeona Stock Surges to 52-Week High: What's Behind The Move? - Benzinga
- 10 days ago - Abeona Therapeutics Wins FDA Approval For First-of-Its-Kind Gene Therapy - Benzinga
- 10 days ago - Abeona spikes on FDA nod for gene therapy - Seeking Alpha
- 10 days ago - US FDA approves Abeona's skin disorder therapy - Reuters
- 10 days ago - U.S. FDA Approves ZEVASKYN™ (prademagene zamikeracel), the First and Only Cell-Based Gene Therapy for Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB) - GlobeNewsWire
- 12 days ago - Undercovered Dozen: 3D Systems, Seritage, Topicus, Timken + - Seeking Alpha